期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Pathologic myopia
1
作者 Kyoko Ohno-Matsui 《Annals of Eye Science》 2018年第1期58-68,共11页
Pathologic myopia is the major cause of the loss of the best-corrected visual acuity(BCVA)worldwide,especially in East Asian countries.The loss of BCVA is caused by the development of myopic macula patchy,myopic tract... Pathologic myopia is the major cause of the loss of the best-corrected visual acuity(BCVA)worldwide,especially in East Asian countries.The loss of BCVA is caused by the development of myopic macula patchy,myopic traction macula patchy,and myopic optic neuropathy(or glaucoma).The development of such vision-threatening complications is caused by eye deformity,characterized by a formation of posterior staphyloma.The recent advance in ocular imaging has greatly facilitated the clarification of pathologies and pathogenesis of pathological myopia and myopia-related complications.These technologies include ultra-wide field fundus imaging,swept-source optical coherence tomography,and 3D MRI.In addition,the new treatments such as anti-VEGF therapies for myopic choroid all neovascularization have improved the outcome of the patients.Swept-source OCT showed that some of the lesions of myopic maculopathy were not simply chorioretinal atrophy but were Bruch’s membrane holes.Features of myopic traction maculopathy have been analyzed extensively by using OCT.The understanding the pathophysiology of complications of pathologic myopia is considered useful for better management of this blinding eye disease. 展开更多
关键词 Pathologic myopia(pm) posterior staphyloma myopic maculopathy myopic traction maculopathy(MTM)
下载PDF
光动力疗法治疗病理性近视脉络膜新生血管20例疗效观察 被引量:2
2
作者 干雪梅 邓雪莲 +3 位作者 贺翔鸽 刘少章 张咏梅 王原 《重庆医学》 CAS CSCD 2008年第24期2813-2814,2816,共3页
目的观察光动力疗法photodynamic therapy(PDT)对病理性近视患者pathological myopia(PM)脉络膜新生血管choroidal neovascularization(CNV)单次和多次治疗的疗效。方法回顾确诊为PMCNV的20例(26眼)其中女性24只眼,男性2只眼... 目的观察光动力疗法photodynamic therapy(PDT)对病理性近视患者pathological myopia(PM)脉络膜新生血管choroidal neovascularization(CNV)单次和多次治疗的疗效。方法回顾确诊为PMCNV的20例(26眼)其中女性24只眼,男性2只眼。进行PDT治疗的疗效。PDT治疗后7d、1个月、3个月、6个月、1年复查。复查FFA显示病灶范围扩大或渗漏增加者重复PDT治疗。结果一般水平分析:显示PDT治疗后视力明显提高,治疗前后视力差异有统计学意义。回归分析显示:(1)女性治疗视力提高的效果不如男性;(2)年龄大的治疗治疗后视力提高效果较差。PDT治疗后复查眼底所见:眼底出血和渗出减轻,FFA检查显示:CNV渗漏明显减少或完全停止。OCT提示CNV周围视网膜脉络膜水肿及神经上皮脱离明显好转。半年后如有CNV复发或扩大者经2~3次PDT后,渗漏逐渐减少。结论单次或重复PDT治疗可以部分或完全封闭脉络膜的CNV,减少CNV引起的视力下降的危险性,PDT治疗不影响病灶周围的视网膜和脉络膜组织。 展开更多
关键词 光动力疗法 病理性近视 脉络膜新生血管
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部